- 专利标题： CIP2A variant and uses thereof
-
申请号： US16765084申请日： 2018-11-20
-
公开(公告)号： US11680092B2公开(公告)日： 2023-06-20
- 发明人: Eleonora Mäkelä , Jukka Westermarck
- 申请人： Turun yliopisto
- 申请人地址： FI Turun yliopisto
- 专利权人： TURUN YLIOPISTO
- 当前专利权人： TURUN YLIOPISTO
- 当前专利权人地址： FI Turun Yliopisto
- 代理机构： Nixon & Vanderhye, P.C.
- 优先权： FI 176032 2017.11.20
- 国际申请： PCT/FI2018/050844 2018.11.20
- 国际公布： WO2019/097122A 2019.05.23
- 进入国家日期： 2020-05-18
- 主分类号： G01N33/00
- IPC分类号： G01N33/00 ; C07K14/82 ; C07K16/18 ; C07K16/30 ; C12Q1/6886 ; G01N33/574
摘要：
The present invention relates to a novel cancer-associated biomarker and different applications and uses thereof. More specifically, the invention relates to a novel splice variant of CIP2A denoted as NOCIVA, as well as binding bodies such as probes, amplification primers, and antibodies specific for the same. Also provided are various methods for detecting and prognosing cancer on the basis of said splice variant, and a kit for use in said methods.
信息查询
